Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

D-19575: new cytostatic drug without renal side effects

Nov. 17, 1997

Clinical results reported for Onco TCS

Nov. 17, 1997

VEGF inhibitors discovered by Zeneca

Nov. 17, 1997

NIH seeks licensees for raf protein kinase therapeutics

Nov. 17, 1997

Ribozyme, Chiron initiate product development of RPI-4610

Nov. 14, 1997

ImClone receives SBIR grant for angiogenesis research

Nov. 14, 1997

Potent antineoplastic camptothecin derivative identified

Nov. 14, 1997

TK inhibitors under development at Dr. Karl Thomae

Nov. 13, 1997

Sankyo synthesizes azole aromatase inhibitors

Nov. 13, 1997

Mitsui Toatsu reveals novel antitumor agents

Nov. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...